SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,009.25 -70.71
( -0.09%)

Global Indices

Nasdaq

53,854.87 63.60
(0.12%)

Dow Jones

7,820.53 51.03
(0.66%)

Hang Seng

68,711.00 402.41
(0.59%)

Nikkei 225

10,757.72 -75.43
(-0.70%)

Forex

USD-INR

95.37 0.00
(0.00%)

EUR-INR

110.01 -0.06
(-0.05%)

GBP-INR

128.81 0.00
(0.00%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

356.2353295

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

50.42

9081.78

EPS(TTM)

Face Value()

Div & Yield %

19.54

0.51

Back

Bodhtree Consulting reports standalone net loss of Rs 1.46 crore in the June 2026 quarter

Aug 12,2026

Net loss of Bodhtree Consulting reported to Rs 1.46 crore in the quarter ended June 2026 as against net profit of Rs 0.31 crore during the previous quarter ended June 2025. Sales rose 1.57% to Rs 1.94 crore in the quarter ended June 2026 as against Rs 1.91 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.94	1.91	2
OPM %	-78.35	17.28	-
PBDT	-1.41	0.34	PL
PBT	-1.46	0.32	PL
NP	-1.46	0.31	PL

78,009.25 -70.71 ( -0.09%)

53,854.87 63.60 (0.12%)

7,820.53 51.03 (0.66%)

68,711.00 402.41 (0.59%)

10,757.72 -75.43 (-0.70%)

95.37 0.00 (0.00%)

110.01 -0.06 (-0.05%)

128.81 0.00 (0.00%)

0.60 0.00 (-0.04%)